ATNM (STOCKS)
Actinium Pharmaceuticals, Inc
$1.110000
+0.030000 (+2.78%)
Prev close: $1.080000
Company Information
- Exchange
- XASE
- Sector
- Health Technology
- Industry
- Pharmaceuticals: Major
- CEO
- Sandesh Seth
- Asset Type
- stocks
- Website
- Visit
Fundamentals
- Market Cap
- $34.83M
- Employees
- 31
- P/E (TTM)
- -1.02
- P/B (TTM)
- 4.30
- Dividend Yield
- —
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Recent News
No recent news found for this ticker.
Financial Statements
| Revenues | $90.00K |
| Benefits Costs and Expenses | $0.00 |
| Costs And Expenses | $36.34M |
| Nonoperating Income/Loss | $2.36M |
| Operating Expenses | $36.34M |
| Research and Development | $21.12M |
| Other Operating Expenses | $15.21M |
| Operating Income/Loss | -$36.25M |
| Income/Loss From Continuing Operations After Tax | -$33.89M |
| Income/Loss From Continuing Operations Before Tax | $90.00K |
| Net Income/Loss | -$33.89M |
| Net Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Net Income/Loss Attributable To Parent | -$33.89M |
| Net Income/Loss Available To Common Stockholders, Basic | -$33.89M |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | $0.00 |
| Preferred Stock Dividends And Other Adjustments | $0.00 |
| Basic Earnings Per Share | -$1.09 |
| Diluted Earnings Per Share | -$1.09 |
| Basic Average Shares | 31,195,891 |
| Diluted Average Shares | 31,195,891 |
| Assets | $51.78M |
| Current Assets | $49.38M |
| Noncurrent Assets | $2.39M |
| Fixed Assets | $295.00K |
| Other Non-current Assets | $2.10M |
| Liabilities | $43.94M |
| Current Liabilities | $7.97M |
| Noncurrent Liabilities | $35.97M |
| Equity | $7.83M |
| Equity Attributable To Noncontrolling Interest | $0.00 |
| Equity Attributable To Parent | $7.83M |
| Liabilities And Equity | $51.78M |
| Net Cash Flow From Operating Activities | -$24.58M |
| Net Cash Flow From Operating Activities, Continuing | -$24.58M |
| Net Cash Flow From Investing Activities | -$104.00K |
| Net Cash Flow From Investing Activities, Continuing | -$104.00K |
| Net Cash Flow From Financing Activities | -$217.00K |
| Net Cash Flow From Financing Activities, Continuing | -$217.00K |
| Exchange Gains/Losses | $6.00K |
| Net Cash Flow | -$24.90M |
| Net Cash Flow, Continuing | -$24.90M |
| Comprehensive Income/Loss | -$33.91M |
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Comprehensive Income/Loss Attributable To Parent | -$33.91M |
| Other Comprehensive Income/Loss | -$33.91M |